Detalles de la búsqueda
1.
The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model.
J Virol
; 96(24): e0173022, 2022 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36448802
2.
The Combination of Venetoclax and Ixazomib Selectively and Efficiently Kills HIV-Infected Cell Lines but Has Unacceptable Toxicity in Primary Cell Models.
J Virol
; 95(12)2021 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33827940
3.
Reactivating latent HIV with PKC agonists induces resistance to apoptosis and is associated with phosphorylation and activation of BCL2.
PLoS Pathog
; 16(10): e1008906, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33075109
4.
A simple automated approach to measure mouse whole gut transit.
Neurogastroenterol Motil
; 33(2): e13994, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33000540
Resultados
1 -
4
de 4
1
Próxima >
>>